» Authors » Dimitrios Dougenis

Dimitrios Dougenis

Explore the profile of Dimitrios Dougenis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 98
Citations 710
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Katsavrias K, Prapas S, Calafiore A, Taggart D, Angouras D, Iliopoulos D, et al.
Front Cardiovasc Med . 2024 Nov; 11:1478166. PMID: 39494236
Background: Since 2000, we have been grafting the right coronary artery system (RCAs) using the proximal portion of the right internal thoracic artery (RITA) as the inflow of the saphenous...
2.
Koutela A, Loudos G, Rouchota M, Kletsas D, Karameris A, Vilaras G, et al.
Diagnostics (Basel) . 2024 Feb; 14(4). PMID: 38396441
Aims: The regeneration of myocardial tissue and the improvement of myocardial activity after ischemia is one of the major areas of interest in cardiovascular research. We developed a novel experimental...
3.
Panagopoulos N, Grapatsas K, Leivaditis V, Galanis M, Dougenis D
Curr Oncol . 2023 Jun; 30(6):5470-5484. PMID: 37366897
Background: Older patients with malignancies are more comorbid than younger ones and are usually undertreated only because of their age. The aim of this study is to investigate the safety...
4.
Koutela A, Loudos G, Rouchota M, Kletsas D, Karameris A, Vilaras G, et al.
In Vivo . 2023 Mar; 37(2):649-654. PMID: 36881049
Background/aim: Myocardial infarction, an acute medical situation with a high mortality rate worldwide, has been extensively studied in modern cardiovascular research, using different experimental models. However, a deep understanding of...
5.
Leivaditis V, Koletsis E, Tsopanoglou N, Charokopos N, DAlessandro C, Grapatsas K, et al.
J Cardiovasc Dev Dis . 2022 Aug; 9(8). PMID: 36005427
(1) Background: The present study aims to investigate the effect of administration of Levosimendan and Exenatide in various concentrations, as well as of the coadministration of those agents in an...
6.
Eforakopoulos F, Koletsis E, Moulakakis K, Charokopos N, Zampakis P, Kalogeropoulou C, et al.
Ann Vasc Surg . 2022 Apr; 85:331-340. PMID: 35395374
Background: Thoracic endovascular aortic repair (TEVAR) is a widely used procedure that has drastically changed the management of thoracic aortic diseases. We assess the effectiveness of supra-aortic debranching during antegrade...
7.
Dimitrakopoulos F, Antonacopoulou A, Kottorou A, Kalofonou M, Panagopoulos N, Dougenis D, et al.
Front Oncol . 2021 Oct; 11:721577. PMID: 34604057
Background: Immune system-related receptors CD40 (tumor necrosis factor receptor superfamily member 5), BAFFR (tumor necrosis factor receptor superfamily member 13C), and LTβR (tumor necrosis factor receptor superfamily member 3) play...
8.
Eforakopoulos F, Giovani M, Zampakis P, Kalogeropoulou C, Fligou F, Charoulis N, et al.
Case Rep Vasc Med . 2021 May; 2021:6380428. PMID: 33954006
Thoracic Endovascular Aortic Repair (TEVAR) has modified aortic medicine, particularly in patients with traumatic aortic injury (TAI). Conventional repair of TAI in the aortic arch is technically demanding as it...
9.
Kollias V, Angouras D, Koufopoulos N, Dougenis D
Interact Cardiovasc Thorac Surg . 2021 Apr; 33(3):499. PMID: 33912957
No abstract available.
10.
Skeparnias I, Anastasakis D, Grafanaki K, Kyriakopoulos G, Alexopoulos P, Dougenis D, et al.
Cancers (Basel) . 2020 Oct; 12(10). PMID: 33092114
Transcriptomics profiles of miRNAs, tRNAs or tRFs are used as biomarkers, after separate examination of several cancer cell lines, blood samples or biopsies. However, the possible contribution of all three...